{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T13:40:17Z","timestamp":1732887617473,"version":"3.30.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Guangdong Basicand Applied Basic Research Foundation","award":["2023A1515110421"],"award-info":[{"award-number":["2023A1515110421"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00203-024-04197-9","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T05:37:49Z","timestamp":1731994669000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["JIB-04, an inhibitor of Jumonji histone demethylase as a potent antitubercular agent against Mycobacterium tuberculosis"],"prefix":"10.1007","volume":"206","author":[{"given":"Pei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senlin","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhou","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"4197_CR1","doi-asserted-by":"publisher","first-page":"20130428","DOI":"10.1098\/rstb.2013.0428","volume":"369","author":"L Abel","year":"2014","unstructured":"Abel L, El-Baghdadi J, Bousfiha AA, Casanova JL, Schurr E (2014) Human genetics of tuberculosis: a long and winding road. Philos Trans R Soc Lond B Biol Sci 369:20130428. https:\/\/doi.org\/10.1098\/rstb.2013.0428","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"4197_CR2","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.1128\/aac.02394-14","volume":"58","author":"A Aono","year":"2014","unstructured":"Aono A, Chikamatsu K, Yamada H, Kato T, Mitarai S (2014) Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis. Antimicrob Agents Chemother 58:4928\u20134930. https:\/\/doi.org\/10.1128\/aac.02394-14","journal-title":"Antimicrob Agents Chemother"},{"key":"4197_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ccm.2023.06.008","volume":"44","author":"T Baird","year":"2023","unstructured":"Baird T, Bell S (2023) Cystic fibrosis-related nontuberculous mycobacterial pulmonary disease. Clin Chest Med 44:847\u2013860. https:\/\/doi.org\/10.1016\/j.ccm.2023.06.008","journal-title":"Clin Chest Med"},{"key":"4197_CR4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/qco.0000000000000104","volume":"27","author":"JL Benwill","year":"2014","unstructured":"Benwill JL, Wallace Jr RJ (2014) Mycobacterium abscessus: challenges in diagnosis and treatment. Curr Opin Infect Dis 27:506\u2013510. https:\/\/doi.org\/10.1097\/qco.0000000000000104","journal-title":"Curr Opin Infect Dis"},{"key":"4197_CR5","first-page":"219","volume":"27","author":"EF Berbari","year":"1998","unstructured":"Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Osmon DR (1998) Prosthetic joint infection due to Mycobacterium tuberculosis: a case series and review of the literature. Am J Orthop (Belle Mead NJ) 27:219\u2013227","journal-title":"Am J Orthop (Belle Mead NJ)"},{"key":"4197_CR6","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/s41467-021-21748-6","volume":"12","author":"P Chakraborty","year":"2021","unstructured":"Chakraborty P, Bajeli S, Kaushal D, Radotra BD, Kumar A (2021) Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis. Nat Commun 12:1606. https:\/\/doi.org\/10.1038\/s41467-021-21748-6","journal-title":"Nat Commun"},{"key":"4197_CR7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00250-2019","author":"S Cowman","year":"2019","unstructured":"Cowman S, van Ingen J, Griffith DE, Loebinger MR (2019) Non-tuberculous mycobacterial pulmonary disease. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.00250-2019","journal-title":"Eur Respir J"},{"key":"4197_CR8","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.celrep.2017.04.077","volume":"19","author":"MP Dalvi","year":"2017","unstructured":"Dalvi MP, Wang L, Zhong R, Kollipara RK, Park H, Bayo J, Yenerall P, Zhou Y, Timmons BC, Rodriguez-Canales J, Behrens C, Mino B, Villalobos P, Parra ER, Suraokar M, Pataer A, Swisher SG, Kalhor N, Bhanu NV, Garcia BA, Heymach JV, Coombes K, Xie Y, Girard L, Gazdar AF, Kittler R, Wistuba II, Minna JD, Martinez ED (2017) Taxane-platin-resistant lung cancers co-develop hypersensitivity to JumonjiC demethylase inhibitors. Cell Rep 19:1669\u20131684. https:\/\/doi.org\/10.1016\/j.celrep.2017.04.077","journal-title":"Cell Rep"},{"key":"4197_CR9","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1093\/jac\/dkq374","volume":"65","author":"JE de Steenwinkel","year":"2010","unstructured":"de Steenwinkel JE, de Knegt GJ, ten Kate MT, van Belkum A, Verbrugh HA, Kremer K, van Soolingen D, Bakker-Woudenberg IA (2010) Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis. J Antimicrob Chemother 65:2582\u20132589. https:\/\/doi.org\/10.1093\/jac\/dkq374","journal-title":"J Antimicrob Chemother"},{"key":"4197_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.chest.2021.07.035","volume":"161","author":"DE Griffith","year":"2022","unstructured":"Griffith DE, Daley CL (2022) Treatment of Mycobacterium abscessus pulmonary disease. Chest 161:64\u201375. https:\/\/doi.org\/10.1016\/j.chest.2021.07.035","journal-title":"Chest"},{"key":"4197_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13148-022-01321-8","volume":"14","author":"Y He","year":"2022","unstructured":"He Y, Yi X, Zhang Z, Luo H, Li R, Feng X, Fang ZM, Zhu XH, Cheng W, Jiang DS, Zhao F, Wei X (2022) JIB-04, a histone demethylase Jumonji C domain inhibitor, regulates phenotypic switching of vascular smooth muscle cells. Clin Epigenet 14:101. https:\/\/doi.org\/10.1186\/s13148-022-01321-8","journal-title":"Clin Epigenet"},{"key":"4197_CR12","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/nature03912","volume":"436","author":"LR Hoffman","year":"2005","unstructured":"Hoffman LR, D\u2019Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI (2005) Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436:1171\u20131175. https:\/\/doi.org\/10.1038\/nature03912","journal-title":"Nature"},{"key":"4197_CR13","doi-asserted-by":"publisher","first-page":"e1005814","DOI":"10.1371\/journal.ppat.1005814","volume":"12","author":"S Holla","year":"2016","unstructured":"Holla S, Prakhar P, Singh V, Karnam A, Mukherjee T, Mahadik K, Parikh P, Singh A, Rajmani RS, Ramachandra SG, Balaji KN (2016) MUSASHI-mediated expression of JMJD3, a H3K27me3 demethylase, is involved in foamy macrophage generation during mycobacterial infection. PLoS Pathog 12:e1005814. https:\/\/doi.org\/10.1371\/journal.ppat.1005814","journal-title":"PLoS Pathog"},{"key":"4197_CR14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","volume":"18","author":"MD Johansen","year":"2020","unstructured":"Johansen MD, Herrmann JL, Kremer L (2020) Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat Rev Microbiol 18:392\u2013407. https:\/\/doi.org\/10.1038\/s41579-020-0331-1","journal-title":"Nat Rev Microbiol"},{"key":"4197_CR15","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/s0272-5231(02)00015-1","volume":"23","author":"D Jones","year":"2002","unstructured":"Jones D, Havlir DV (2002) Nontuberculous mycobacteria in the HIV infected patient. Clin Chest Med 23:665\u2013674. https:\/\/doi.org\/10.1016\/s0272-5231(02)00015-1","journal-title":"Clin Chest Med"},{"key":"4197_CR16","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.1038\/s41598-018-24903-0","volume":"8","author":"MS Kim","year":"2018","unstructured":"Kim MS, Cho HI, Yoon HJ, Ahn YH, Park EJ, Jin YH, Jang YK (2018) JIB-04, a small molecule histone demethylase inhibitor, selectively targets colorectal cancer stem cells by inhibiting the Wnt\/\u03b2-catenin signaling pathway. Sci Rep 8:6611. https:\/\/doi.org\/10.1038\/s41598-018-24903-0","journal-title":"Sci Rep"},{"key":"4197_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147657","author":"J Lee","year":"2022","unstructured":"Lee J, Kim JS, Cho HI, Jo SR, Jang YK (2022) JIB-04, a pan-inhibitor of histone demethylases, targets histone-lysine-demethylase-dependent AKT pathway, leading to cell cycle arrest and inhibition of cancer stem-like cell properties in hepatocellular carcinoma cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23147657","journal-title":"Int J Mol Sci"},{"key":"4197_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.gendis.2023.02.041","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Ding L, Zhang Y, Zhou B, Wai Man GC, Wang M, Li J, Liu Y, Lin W, Wang H, Lin S, Xu L (2024) Histone demethylase Kdm5c regulates osteogenesis and bone formation via PI3K\/Akt\/HIF1\u03b1 and Wnt\/\u03b2-catenin signaling pathways. Genes Dis 11:64\u201366. https:\/\/doi.org\/10.1016\/j.gendis.2023.02.041","journal-title":"Genes Dis"},{"key":"4197_CR19","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1128\/aac.47.11.3616-3619.2003","volume":"47","author":"A Martin","year":"2003","unstructured":"Martin A, Camacho M, Portaels F, Palomino JC (2003) Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother 47:3616\u20133619. https:\/\/doi.org\/10.1128\/aac.47.11.3616-3619.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"4197_CR20","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1371\/journal.pmed.0030466","volume":"3","author":"M Matsumoto","year":"2006","unstructured":"Matsumoto M, Hashizume H, Tomishige T, Kawasaki M, Tsubouchi H, Sasaki H, Shimokawa Y, Komatsu M (2006) OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. PLoS Med 3:e466. https:\/\/doi.org\/10.1371\/journal.pmed.0030466","journal-title":"PLoS Med"},{"key":"4197_CR21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2217\/fmb.10.50","volume":"5","author":"A Matteelli","year":"2010","unstructured":"Matteelli A, Carvalho AC, Dooley KE, Kritski A (2010) TMC207: the first compound of a new class of potent anti-tuberculosis drugs. Future Microbiol 5:849\u2013858. https:\/\/doi.org\/10.2217\/fmb.10.50","journal-title":"Future Microbiol"},{"key":"4197_CR22","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/jam.12272","volume":"115","author":"SN Mullis","year":"2013","unstructured":"Mullis SN, Falkinham JO (2013) Adherence and biofilm formation of Mycobacterium avium, Mycobacterium intracellulare and Mycobacterium abscessus to household plumbing materials. J Appl Microbiol 115:908\u2013914. https:\/\/doi.org\/10.1111\/jam.12272","journal-title":"J Appl Microbiol"},{"key":"4197_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.advms.2015.09.007","volume":"61","author":"M Njire","year":"2016","unstructured":"Njire M, Tan Y, Mugweru J, Wang C, Guo J, Yew W, Tan S, Zhang T (2016) Pyrazinamide resistance in Mycobacterium tuberculosis: review and update. Adv Med Sci 61:63\u201371. https:\/\/doi.org\/10.1016\/j.advms.2015.09.007","journal-title":"Adv Med Sci"},{"key":"4197_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2005.09.012","volume":"123","author":"A Ojha","year":"2005","unstructured":"Ojha A, Anand M, Bhatt A, Kremer L, Jacobs WR Jr., Hatfull GF (2005) GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell 123:861\u2013873. https:\/\/doi.org\/10.1016\/j.cell.2005.09.012","journal-title":"Cell"},{"key":"4197_CR25","doi-asserted-by":"publisher","first-page":"33110","DOI":"10.18632\/oncotarget.26011","volume":"9","author":"JK Parrish","year":"2018","unstructured":"Parrish JK, McCann TS, Sechler M, Sobral LM, Ren W, Jones KL, Tan AC, Jedlicka P (2018) The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth. Oncotarget 9:33110\u201333123. https:\/\/doi.org\/10.18632\/oncotarget.26011","journal-title":"Oncotarget"},{"key":"4197_CR26","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1007\/s00044-016-1599-6","volume":"25","author":"M Pitucha","year":"2016","unstructured":"Pitucha M, Wo\u015b M, Miazga-Karska M, Klimek K, Miros\u0142aw B, Pachuta-Stec A, G\u0142adysz A, Ginalska G (2016) Synthesis, antibacterial and antiproliferative potential of some new 1-pyridinecarbonyl-4-substituted thiosemicarbazide derivatives. Med Chem Res Int J Rapid Commun Des Mech Action Biol Act Agents 25:1666\u20131677. https:\/\/doi.org\/10.1007\/s00044-016-1599-6","journal-title":"Med Chem Res Int J Rapid Commun Des Mech Action Biol Act Agents"},{"key":"4197_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/ijmy.ijmy_228_20","volume":"10","author":"TV Polyudova","year":"2021","unstructured":"Polyudova TV, Eroshenko DV, Pimenova EV (2021) The biofilm formation of nontuberculous mycobacteria and its inhibition by essential oils. Int J Mycobacteriol 10:43\u201350. https:\/\/doi.org\/10.4103\/ijmy.ijmy_228_20","journal-title":"Int J Mycobacteriol"},{"key":"4197_CR28","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41419-018-1110-z","volume":"9","author":"C Poulard","year":"2018","unstructured":"Poulard C, Baulu E, Lee BH, Pufall MA, Stallcup MR (2018) Increasing G9a automethylation sensitizes B acute lymphoblastic leukemia cells to glucocorticoid-induced death. Cell Death Dis 9:1038. https:\/\/doi.org\/10.1038\/s41419-018-1110-z","journal-title":"Cell Death Dis"},{"key":"4197_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","volume":"36","author":"DR Prevots","year":"2015","unstructured":"Prevots DR, Marras TK (2015) Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med 36:13\u201334. https:\/\/doi.org\/10.1016\/j.ccm.2014.10.002","journal-title":"Clin Chest Med"},{"key":"4197_CR30","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccm.2023.06.012","volume":"44","author":"A Sawka","year":"2023","unstructured":"Sawka A, Burke A (2023) Medications and monitoring in treatment of nontuberculous mycobacterial pulmonary disease. Clin Chest Med 44:815\u2013828. https:\/\/doi.org\/10.1016\/j.ccm.2023.06.012","journal-title":"Clin Chest Med"},{"key":"4197_CR31","doi-asserted-by":"publisher","first-page":"e0169421","DOI":"10.1128\/jcm.01694-21","volume":"60","author":"SJ Shallom","year":"2022","unstructured":"Shallom SJ, Zelazny AM (2022) Detection of mixed populations of clarithromycin-susceptible and -resistant Mycobacterium abscessus strains. J Clin Microbiol 60:e0169421. https:\/\/doi.org\/10.1128\/jcm.01694-21","journal-title":"J Clin Microbiol"},{"key":"4197_CR32","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1126\/science.1164571","volume":"322","author":"R Singh","year":"2008","unstructured":"Singh R, Manjunatha U, Boshoff HI, Ha YH, Niyomrattanakit P, Ledwidge R, Dowd CS, Lee IY, Kim P, Zhang L, Kang S, Keller TH, Jiricek J, Barry CE (2008) PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science (New York NY) 322:1392\u20131395. https:\/\/doi.org\/10.1126\/science.1164571","journal-title":"Science (New York NY)"},{"key":"4197_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112631","author":"B Singh","year":"2022","unstructured":"Singh B, Sarli VN, Lucci A (2022) Sensitization of resistant breast cancer cells with a jumonji family histone demethylase inhibitor. Cancers. https:\/\/doi.org\/10.3390\/cancers14112631","journal-title":"Cancers"},{"key":"4197_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1128\/cmr.16.3.463-496.2003","volume":"16","author":"I Smith","year":"2003","unstructured":"Smith I (2003) Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 16:463\u2013496. https:\/\/doi.org\/10.1128\/cmr.16.3.463-496.2003","journal-title":"Clin Microbiol Rev"},{"key":"4197_CR35","doi-asserted-by":"publisher","first-page":"e0337721","DOI":"10.1128\/mbio.03377-21","volume":"13","author":"J Son","year":"2022","unstructured":"Son J, Huang S, Zeng Q, Bricker TL, Case JB, Zhou J, Zang R, Liu Z, Chang X, Darling TL, Xu J, Harastani HH, Chen L, Gomez Castro MF, Zhao Y, Kohio HP, Hou G, Fan B, Niu B, Guo R, Rothlauf PW, Bailey AL, Wang X, Shi PY, Martinez ED, Brody SL, Whelan SPJ, Diamond MS, Boon ACM, Li B, Ding S (2022) JIB-04 has broad-spectrum antiviral activity and inhibits SARS-CoV-2 replication and coronavirus pathogenesis. mBio 13:e0337721. https:\/\/doi.org\/10.1128\/mbio.03377-21","journal-title":"mBio"},{"key":"4197_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/s0883-5403(05)80023-3","volume":"11","author":"RJ Spinner","year":"1996","unstructured":"Spinner RJ, Sexton DJ, Goldner RD, Levin LS (1996) Periprosthetic infections due to Mycobacterium tuberculosis in patients with no prior history of tuberculosis. J Arthroplast 11:217\u2013222. https:\/\/doi.org\/10.1016\/s0883-5403(05)80023-3","journal-title":"J Arthroplast"},{"key":"4197_CR37","doi-asserted-by":"publisher","unstructured":"Syal K, Flentie K, Bhardwaj N, Maiti K, Jayaraman N, Stallings CL, Chatterji D (2017) Synthetic (p)ppGpp analogue is an inhibitor of stringent response in mycobacteria. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/aac.00443-17","DOI":"10.1128\/aac.00443-17"},{"key":"4197_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/clinids\/21.1.134","volume":"21","author":"JI Tokumoto","year":"1995","unstructured":"Tokumoto JI, Follansbee SE, Jacobs RA (1995) Prosthetic joint infection due to Mycobacterium tuberculosis: report of three cases. Clin Infect Dis Off Publ Infect Dis Soc Am 21:134\u2013136. https:\/\/doi.org\/10.1093\/clinids\/21.1.134","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"4197_CR39","doi-asserted-by":"publisher","first-page":"11392","DOI":"10.1038\/ncomms11392","volume":"7","author":"A Trivedi","year":"2016","unstructured":"Trivedi A, Mavi PS, Bhatt D, Kumar A (2016) Thiol reductive stress induces cellulose-anchored biofilm formation in Mycobacterium tuberculosis. Nat Commun 7:11392. https:\/\/doi.org\/10.1038\/ncomms11392","journal-title":"Nat Commun"},{"key":"4197_CR40","doi-asserted-by":"publisher","unstructured":"Wang L, Chang J, Varghese D, Dellinger M, Kumar S, Best AM, Ruiz J, Bruick R, Pe\u00f1a-Llopis S, Xu J, Babinski DJ, Frantz DE, Brekken RA, Quinn AM, Simeonov A, Easmon J, Martinez ED (2013) A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth. Nat Commun\u00a04:2035. https:\/\/doi.org\/10.1038\/ncomms3035","DOI":"10.1038\/ncomms3035"},{"key":"4197_CR41","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1021\/acsinfecdis.2c00096","volume":"8","author":"T Wang","year":"2022","unstructured":"Wang T, Yang W, Liu Y, Li W, Wang Y, Liu N, Sheng C (2022) Jumonji histone demethylase inhibitor JIB-04 as a broad-spectrum antifungal agent. ACS Infect Dis 8:1316\u20131323. https:\/\/doi.org\/10.1021\/acsinfecdis.2c00096","journal-title":"ACS Infect Dis"},{"key":"4197_CR42","doi-asserted-by":"publisher","first-page":"113742","DOI":"10.1016\/j.yexcr.2023.113742","volume":"431","author":"X Wang","year":"2023","unstructured":"Wang X, Zhang C, Dong N, Xu H, Zhou Y, Hou D (2023) E2F1-driven histone demethylase KDM6B enhances thyroid malignancy via manipulating TFEB-dependent autophagy axis. Exp Cell Res 431:113742. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113742","journal-title":"Exp Cell Res"},{"key":"4197_CR43","doi-asserted-by":"publisher","first-page":"Cd010004","DOI":"10.1002\/14651858.CD010004.pub5","volume":"6","author":"V Waters","year":"2020","unstructured":"Waters V, Ratjen F (2020) Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database Syst Rev 6:Cd010004. https:\/\/doi.org\/10.1002\/14651858.CD010004.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"4197_CR44","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1128\/iai.64.6.2062-2069.1996","volume":"64","author":"LG Wayne","year":"1996","unstructured":"Wayne LG, Hayes LG (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64:2062\u20132069. https:\/\/doi.org\/10.1128\/iai.64.6.2062-2069.1996","journal-title":"Infect Immun"},{"key":"4197_CR45","volume-title":"Global tuberculosis report 2022","author":"WHO","year":"2022","unstructured":"WHO (2022) Global tuberculosis report 2022. World Health Organization, Geneva"},{"key":"4197_CR46","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1513\/AnnalsATS.201804-236OC","volume":"17","author":"KL Winthrop","year":"2020","unstructured":"Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q (2020) Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008\u20132015. Ann Am Thorac Soc 17:178\u2013185. https:\/\/doi.org\/10.1513\/AnnalsATS.201804-236OC","journal-title":"Ann Am Thorac Soc"},{"key":"4197_CR47","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/j.1462-5822.2005.00667.x","volume":"8","author":"Y Yamazaki","year":"2006","unstructured":"Yamazaki Y, Danelishvili L, Wu M, Hidaka E, Katsuyama T, Stang B, Petrofsky M, Bildfell R, Bermudez LE (2006) The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells. Cell Microbiol 8:806\u2013814. https:\/\/doi.org\/10.1111\/j.1462-5822.2005.00667.x","journal-title":"Cell Microbiol"},{"key":"4197_CR48","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MGM2-0023-2013","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Shi W, Zhang W, Mitchison D (2014) Mechanisms of pyrazinamide action and resistance. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.MGM2-0023-2013","journal-title":"Microbiol Spectr"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-024-04197-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-024-04197-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-024-04197-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T09:11:04Z","timestamp":1732785064000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-024-04197-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["4197"],"URL":"https:\/\/doi.org\/10.1007\/s00203-024-04197-9","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"type":"print","value":"0302-8933"},{"type":"electronic","value":"1432-072X"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"470"}}